MENU
+Compare
MLYS
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$9.56
Change
+$0.03 (+0.31%)
Capitalization
476.43M

MLYS Mineralys Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MLYS with price predictions
Feb 21, 2025

MLYS in +2.57% Uptrend, rising for three consecutive days on February 21, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MLYS advanced for three days, in of 104 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MLYS's RSI Oscillator exited the oversold zone, of 14 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for MLYS just turned positive on January 28, 2025. Looking at past instances where MLYS's MACD turned positive, the stock continued to rise in of 19 cases over the following month. The odds of a continued upward trend are .

MLYS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 62 cases where MLYS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 13, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MLYS as a result. In of 30 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for MLYS moved below the 200-day moving average on January 15, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MLYS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.491) is normal, around the industry mean (12.481). P/E Ratio (0.000) is within average values for comparable stocks, (84.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). MLYS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (251.221).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MLYS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MLYS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MLYS is expected to report earnings to rise 10.20% to -108 cents per share on May 19

Mineralys Therapeutics MLYS Stock Earnings Reports
Q1'25
Est.
$-1.08
Q4'24
Missed
by $0.27
Q3'24
Missed
by $0.42
Q2'24
Missed
by $0.11
Q1'24
Beat
by $0.02
The last earnings report on February 12 showed earnings per share of -98 cents, missing the estimate of -70 cents. With 335.44K shares outstanding, the current market capitalization sits at 476.43M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
150 North Radnor Chester Road
Phone
+1 888 378-6240
Employees
28
Web
https://mineralystx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HDRVX16.63-0.04
-0.24%
Janus Henderson Responsible Intl DivN
VCGAX34.64-0.62
-1.76%
VALIC Company I Systematic Core Fund
FSSKX80.14-1.61
-1.97%
Fidelity Stock Selec-Class K
EMCAX64.07-1.85
-2.81%
Empiric Class A
HCMIX29.55-1.08
-3.53%
HCM Tactical Growth I

MLYS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with ABOS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
+0.31%
ABOS - MLYS
45%
Loosely correlated
+0.72%
IDYA - MLYS
40%
Loosely correlated
+0.55%
CELC - MLYS
40%
Loosely correlated
+0.15%
RCKT - MLYS
40%
Loosely correlated
-3.68%
ERAS - MLYS
39%
Loosely correlated
-3.42%
More